What lies ahead for Infection Imaging- Sanjay K Jain

IASNM Radiant Flashpoints Educational Web-Series – November 1, 2025 

IASNM Radiant Flashpoints Educational Web-Series – November 1, 2025 (Saturday)
Time: 10:00 am (EST), 7:00 am Pacific, India: 7:30 pm

Sanjay K Jain, MD
Professor of Pediatrics,
Radiology & Radiological Sciences and International Health,
Johns Hopkins University

Topic: What lies ahead for Infection Imaging?

Objectives
📌 Recognize the heterogeneity in infectious lesions and pathology.
📌 Understand the basis for new molecular imaging agents being developed for pathogen-specific imaging.
📌 Understand the kinetics of whole-body antimicrobial distribution, including spatial compartmentalization and temporal changes with treatment.

Sanjay K Jain, M.D. is Professor of Pediatrics, Radiology & Radiological Sciences and International Health at the Johns Hopkins University. He directs the Center for Infection and Inflammation Imaging Research and is a member of the Center for TB Research at Johns Hopkins. Dr. Jain is also the Vice Chair for Basic & Translational Research in the Department of Pediatrics. His primary research interests include the development of novel molecular imaging technologies for bacterial infections, pediatric tuberculosis (TB), and TB meningitis.

Dr. Jain’s laboratory conducts animal and human studies to develop and evaluate novel radiopharmaceutical imaging methods (CT, PET, SPECT, MRI) to understand disease pathogenesis (e.g. study antimicrobial pharmacokinetics at infection sites) and pathogen-specific imaging diagnostics. Several novel tracers developed in his laboratory are now being tested in first-in-human studies. For example, they have performed first-in-human studies using a radiolabeled version of rifampin and pretomanid (important antibiotics) in humans with TB or S. aureus infections to test whether these antibiotics achieves adequate levels at the infection sites. Similarly, his group is evaluating novel pathogen-specific PET tracers to noninvasively detect invasive bacterial and fungal infections in patients.

Dr. Jain is funded though several grants. Notably, he is also the recipient of the prestigious NIH Director’s New Innovator Award (2009) and the NIH Director’s Transformative Research Award (2014). Dr. Jain is the past chair (2014-2021) and a founding member of the Infectious Diseases subgroup and current board member and Executive committee member of the World Molecular Imaging Society. He serves as a reviewer for multiple scientific journals and NIH study panels.




Share:

More Posts

Send Us A Message

More Posts